N-(2-ethanoyloxyethyl)morpholine | 13276-24-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: N-(2-ethanoyloxyethyl)morpholine
• 英文别名: Essigsaeure-<2-morpholino-aethylester>；1-acetoxy-2-morpholin-4-yl-ethane；2-morpholinoethyl acetate；N-(2-acetoxyethyl)morpholine；2-morpholin-4-ylethyl acetate
• CAS: 13276-24-9
• 化学式: C₈H₁₅NO₃
• mdl: MFCD28132045
• 分子量: 173.212
• InChiKey: ZDTRMJAWAIZCSV-UHFFFAOYSA-N

物化性质

• 沸点：
  69-70 °C(Press: 3 Torr)
• 密度：
  1.0723 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.875
• 拓扑面积：
  38.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  2-吗啉乙醇 、 溶剂黄146 以 甲苯 为溶剂， 以70%的产率得到N-(2-ethanoyloxyethyl)morpholine
  参考文献：
  名称：

  Synthesis of N-Substituted Oxazolidines and Morpholines

  摘要：

  一系列N-取代的噁唑烷和吗啉被制备并进行了表征。

  DOI：

  10.1007/s11167-005-0502-x

文献信息

• MONOMERS, POLYMERS AND PHOTORESIST COMPOSITIONS
  申请人：Rohm and Haas Electronic Materials Korea Ltd.

  公开号：US20180059545A1

  公开（公告）日：2018-03-01

  In one preferred embodiment, polymers are provided that comprise a structure of the following Formula (I): Photoresists that comprises such polymers also are provided.

  在一个首选实施例中，提供了包含以下化学式（I）结构的聚合物： 还提供了包含这种聚合物的光刻胶。
• Novel sulfonyldiazomethanes, photoacid generators, resist compositions, and patterning process
  申请人：——

  公开号：US20040167322A1

  公开（公告）日：2004-08-26

  A chemical amplification type resist composition comprising a specific benzenesulfonyldiazomethane containing a long-chain alkoxyl group at the 2-position on benzene ring has many advantages including improved resolution, improved focus latitude, minimized line width variation or shape degradation even on long-term PED, minimized debris left after coating, development and peeling, and improved pattern profile after development and is thus suited for microfabrication.

  一种化学放大型抗蚀组合物，包括在苯环上的2-位含有长链烷氧基基团的特定苯磺酰二氮甲烷，具有许多优点，包括提高分辨率，改善焦点宽度，即使在长期PED上也减少线宽变化或形状退化，涂层、显影和剥离后减少残留物，并在显影后改善图案轮廓，因此适用于微加工。
• COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
  申请人：Global Blood Therapeutics, Inc.

  公开号：US20150141465A1

  公开（公告）日：2015-05-21

  Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.

  本文提供了适用作为血红蛋白调节剂的化合物和药物组合物，它们的制备方法和中间体，以及在治疗由血红蛋白介导的疾病和需要组织和/或细胞氧合的疾病中使用它们的方法。
• BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
  申请人：Global Blood Therapeutics, Inc.

  公开号：US20150259296A1

  公开（公告）日：2015-09-17

  Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.

  本文提供了适用作为血红蛋白调节剂的化合物和药物组合物，它们的制备方法和中间体，以及在治疗由血红蛋白介导的疾病和需要组织和/或细胞氧合的疾病中使用它们的方法。
• THERAPEUTIC PROSTAGLANDIN RECEPTOR AGONISTS
  申请人：Allergan, Inc.

  公开号：US20150329518A1

  公开（公告）日：2015-11-19

  Described herein are compounds which can be used in topical liquids, creams, or other dosage forms such as solids, for reducing intraocular pressure, treating glaucoma, growing hair, treating wounds, or other medical and/or cosmetic uses.

  本文描述了可以用于局部液体、乳霜或其他剂型（如固体）中的化合物，用于降低眼内压、治疗青光眼、促进头发生长、治疗伤口或其他医疗和/或化妆用途。